breadth under the surface is deteriorating; more importantly, estimates are being cut and margins are slipping. The tail risk is a macro shock that overrides fundamentals
i’d take this side. fundamentally it works: the antitrust remedies overhang the stock — that's the real path to $325. the antitrust remedies overhang the stock. could go either way tbh.